BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Staging
605 results:

  • 1. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
    Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
    BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study.
    McLeod M; Torode J; Leung K; Bhoo-Pathy N; Booth C; Chakowa J; Gralow J; Ilbawi A; Jassem J; Parkes J; Mallafré-Larrosa M; Mutebi M; Pramesh CS; Sengar M; Tsunoda A; Unger-Saldaña K; Vanderpuye V; Yusuf A; Sullivan R; Aggarwal A
    Lancet Oncol; 2024 Feb; 25(2):e63-e72. PubMed ID: 38301704
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Expressions of NLRP3, Caspase-1, and GSDMD in nasopharyngeal carcinoma tissue and association with recurrence and metastasis].
    Liu D; Wan L; Peng C; Cen RX; Xu F
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Dec; 58(12):1215-1224. PubMed ID: 38186096
    [No Abstract]    [Full Text] [Related]  

  • 4. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid cancer in the West of Scotland: A Retrospective Analysis.
    Graham K; Tough F; Belikova H; Wotherspoon I; Colville D; Reed N
    Endocr Pract; 2024 Apr; 30(4):327-332. PubMed ID: 38184240
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical and pathological correlation of P
    Ravishankar B; Madhavi BV; Kalagara A; Bodepudi S; Harnadh S; Bindu PJ; Pydi VR; Raj BP; Nitya G; Rishik B
    Pathol Res Pract; 2024 Jan; 253():155071. PubMed ID: 38181580
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
    Cooper DJ; Ziemba Y; Pereira L; Kann BH; Parashar B; Miles BA; Ghaly M; Seetharamu N; Frank D; Talcott WJ
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):151-156. PubMed ID: 38175664
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radiomics analysis for the prediction of locoregional recurrence of locally advanced oropharyngeal cancer and hypopharyngeal cancer.
    Wu TC; Liu YL; Chen JH; Chen TY; Ko CC; Lin CY; Kao CY; Yeh LR; Su MY
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1473-1481. PubMed ID: 38127096
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
    Park HC; Kim H; Kim JY; Lee HY; Lee J; Cha W; Ahn SH; Jeong WJ
    BMC Cancer; 2023 Dec; 23(1):1242. PubMed ID: 38104103
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Social Vulnerability Association with Thyroid cancer Disparities in the United States.
    Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
    [No Abstract]    [Full Text] [Related]  

  • 10. Oncologic Outcome in Advanced Oral Squamous Cell Carcinoma After Refusal of Recommended Adjuvant Therapy.
    Mrosk F; Doll C; Scheer J; Neumann F; Hofmann E; Kreutzer K; Voss J; Rubarth K; Beck M; Heiland M; Koerdt S
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1027-1033. PubMed ID: 37824130
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid cancer.
    Roh YH; Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    Korean J Radiol; 2023 Oct; 24(10):1028-1037. PubMed ID: 37793671
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-term follow-up of osteoradionecrosis of the mandible.
    Boromand G; Haugen-Cange H; Asparusova M; Ekestubbe A; Kjeller G
    Acta Odontol Scand; 2024 Jan; 82(1):48-54. PubMed ID: 37772879
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical evaluation of radiation-induced sinusitis by MRI-based scoring system in nasopharyngeal carcinoma patients.
    Zheng W; Yan T; Liu D; Chen G; Wen Y; Rao X; Wang Y; Zheng H; Yang J; Peng H
    Radiat Oncol; 2023 Sep; 18(1):153. PubMed ID: 37723540
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A gradient mapping guided explainable deep neural network for extracapsular extension identification in 3D head and neck cancer computed tomography images.
    Wang Y; Rahman A; Duggar WN; Thomas TV; Roberts PR; Vijayakumar S; Jiao Z; Bian L; Wang H
    Med Phys; 2024 Mar; 51(3):2007-2019. PubMed ID: 37643447
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Changes in Sarcopenia Status Predict Survival Among Patients with Resectable Esophageal cancer.
    Jogiat UM; Baracos V; Turner SR; Eurich D; Filafilo H; Rouhi A; Bédard A; Bédard ELR
    Ann Surg Oncol; 2023 Nov; 30(12):7412-7421. PubMed ID: 37466867
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?
    Vo K; Ladbury C; Tam A; Maghami E; Kang R; Villaflor V; Agulnik M; Gernon T; Glaser S; Amini A
    Head Neck; 2023 Aug; 45(8):2079-2086. PubMed ID: 37345637
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma.
    Sun W; Veeramachaneni N; Al-Rajabi R; Madan R; Kasi A; Al-Kasspooles M; Baranda J; Saeed A; Phadnis MA; Godwin AK; Olyaee M; Streeter N; Nagji A; Dai J; Williamson S
    Cancer Med; 2023 Aug; 12(15):16098-16107. PubMed ID: 37326317
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas.
    de Morais EF; Almangush A; Salo T; da Silva SD; Kujan O; Coletta RD
    Histol Histopathol; 2024 Jan; 39(1):1-12. PubMed ID: 37310089
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of MRI on the post-therapeutic diagnosis of T4 esophageal cancer.
    Harino T; Yamasaki M; Murai S; Yamashita K; Tanaka K; Makino T; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Tomiyama N; Eguchi H; Nakamura H; Doki Y
    Esophagus; 2023 Oct; 20(4):740-748. PubMed ID: 37233847
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.